Low IMA Ligation Did Not Significantly Reduce Leaks

• by Andrea Surnit

• July 15, 2026

FDA clears targeted cholangiocarcinoma therapy

In the single-arm REFOCUS trial, 46% of patients responded to treatment, with a median response duration of 11.8 months.

• by Kathryn Wighton

• September 24, 2026

• 2 min

Prehabilitation Program May Benefit Patients Undergoing CRC Surgery

Structured implementation increased participation and improved preoperative fitness, while postoperative complication and mortality rates remained similar across groups.

• by Andrea Surnit

• June 25, 2026

• 4 min

Impact of powered circular stapling devices on anastomotic leakage rates in colorectal surgery

• by Catherine Kollmann, Theresa Eckart, Beata Kusnezov, Lars Kollmann, Matthias Kelm, Christoph-Thomas Germer, Johan Friso Lock, Sven Flemming

• July 8, 2026